What is Chronic Thromboembolic Pulmonary Hypertension (CTEPH)?
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is a rare and severe form of pulmonary hypertension. It is characterized by the presence of organized blood clots that obstruct the pulmonary arteries, leading to increased pressure in these vessels. This increased pressure, in turn, places a significant strain on the right side of the heart, which can lead to right heart failure if left untreated. [1] [2]
The Development of CTEPH
CTEPH is a long-term complication of pulmonary embolism (PE), a condition where a blood clot travels to the lungs. While most pulmonary emboli resolve with anticoagulant therapy, in a small percentage of cases, the clots do not dissolve completely. Instead, they adhere to the walls of the pulmonary arteries and, over time, become organized into fibrous, scar-like tissue. This process of organization and remodeling leads to the narrowing or complete blockage of the pulmonary arteries, resulting in the elevated pulmonary artery pressures that define CTEPH. [1] [2]
Risk Factors
Several factors have been identified that may increase the risk of developing CTEPH after a pulmonary embolism. These include:
- **Large or recurrent pulmonary emboli:** Individuals who have experienced a massive PE or multiple PEs are at a higher risk.
- **Chronic inflammatory conditions:** Conditions such as inflammatory bowel disease and osteomyelitis have been associated with an increased risk.
- **Certain blood disorders:** Blood disorders that increase the risk of clotting, such as antiphospholipid syndrome, can predispose individuals to CTEPH.
- **Splenectomy:** The absence of a spleen has been identified as a risk factor.
- **Blood type:** Individuals with non-O blood types may have a slightly higher risk. [1]
Symptoms
The symptoms of CTEPH are often nonspecific and can be similar to those of other heart and lung conditions, which can make diagnosis challenging. The most common symptom is shortness of breath, particularly with physical exertion. Other symptoms may include:
- Fatigue
- Chest pain
- Dizziness or fainting
- Swelling in the legs and ankles (edema)
- A bluish discoloration of the skin (cyanosis)
- Heart palpitations [1]
Diagnosis
Diagnosing CTEPH typically involves a series of tests to confirm the presence of pulmonary hypertension and to identify the organized clots in the pulmonary arteries. These tests may include:
- **Echocardiogram:** This non-invasive test uses sound waves to create images of the heart, allowing doctors to assess the size and function of the right ventricle and to estimate the pulmonary artery pressure.
- **Ventilation-perfusion (V/Q) scan:** This imaging test is a key tool for diagnosing CTEPH. It can detect mismatched areas of ventilation and blood flow in the lungs, which is a hallmark of the disease.
- **Right heart catheterization:** This invasive procedure is the gold standard for diagnosing pulmonary hypertension. It involves inserting a thin, flexible tube into a vein and guiding it to the right side of the heart and pulmonary arteries to directly measure the pressures.
- **Pulmonary angiography:** This imaging test uses a contrast dye to visualize the pulmonary arteries and to identify the location and extent of the blockages. [1]
Treatment
CTEPH is unique among the different types of pulmonary hypertension in that it is potentially curable. The primary treatment for CTEPH is a surgical procedure called pulmonary endarterectomy (PEA). During this complex operation, a surgeon removes the organized clots and scar tissue from the lining of the pulmonary arteries, restoring normal blood flow. For patients who are not candidates for PEA, other treatment options are available, including:
- **Balloon pulmonary angioplasty (BPA):** This is a less invasive procedure in which a balloon is used to open up the narrowed pulmonary arteries.
- **Medical therapy:** Certain medications, such as riociguat, can help to lower the pressure in the pulmonary arteries and improve symptoms. [1]
Conclusion
CTEPH is a serious and progressive disease, but with timely diagnosis and appropriate treatment, the outlook for patients can be significantly improved. It is crucial for individuals who have had a pulmonary embolism to be aware of the symptoms of CTEPH and to seek medical attention if they experience persistent or worsening shortness of breath. Early detection and treatment are key to preventing the long-term complications of this potentially curable condition.
References
[1] Cleveland Clinic. (2022, July 29). *Chronic Thromboembolic Pulmonary Hypertension (CTEPH)*. Retrieved from https://my.clevelandclinic.org/health/diseases/17635-chronic-thromboembolic-pulmonary-hypertension-cteph
[2] American Lung Association. (n.d.). *Chronic Thromboembolic Pulmonary Hypertension (CTEPH)*. Retrieved from https://www.lung.org/lung-health-diseases/lung-disease-lookup/cteph